Injective’s latest governance vote on the Veyra mainnet upgrade feels like a big step, but $INJ is down 5% on a 7.426 price and the market volume is modest. The upgrade could boost confidence, yet the price slump suggests investors are still wary. I think the narrative is a bit ahead of the evidence – the upgrade is good, but the current market sentiment hasn’t warmed up yet. DYOR.